Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial
Discussion
Topical steroids have shown promise for treating ocular complications of TEN, but to date have not been evaluated for cutaneous manifestations of the disease. This trial will investigate clinical and molecular outcomes of topical clobetasol application and hopefully provide insight into the disease pathophysiology.
Trial registration
ClinicalTrials.gov NCT02319616. https://clinicaltrials.gov/ct2/show/NCT02351037 (Source: Trials)
Source: Trials - August 22, 2015 Category: Research Source Type: clinical trials
Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser
Conditions: Lentigines; Post Inflammatory HyperpigmentationInterventions: Drug: topical 0.05% Clobetasol propionate ointment; Device: Q switched Nd:YAG laser 532 nmSponsor: Mahidol UniversityActive, not recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2015 Category: Research Source Type: clinical trials
Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser
Condition: Vulvar Lichen SclerosusInterventions: Drug: Clobetasol propionate; Radiation: Photodynamic therapy; Radiation: Low level laser therapySponsors: Daniela de Fátima Teixeira da Silva; Hospital Perola ByingtonRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2015 Category: Research Source Type: clinical trials
